siRNA targeting angiotensinogen (Leaderna Therapeutics)

N/A

Report date: 2025/06/11 10:45:23
NME

Base Information

Drug NamesiRNA targeting angiotensinogen (Leaderna Therapeutics)
Drug Alias NameAGT siRNA therapy (Leaderna Therapeutics)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiotensinogen inhibitors
TargetsAngiotensinogen
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLeaderna Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLeaderna Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A